INTRODUCTION
Neisseria meningitidis frequently colonizes nasopharyngeal mucosal membranes and occasionally causes life-threatening diseases, such as meningitis and septicaemia [Reference DeVoe1, Reference Rosenstein2]. An estimated 100 000 cases of N. meningitidis infection are reported worldwide each year despite the existence of partially effective vaccines [3]. More than ten serogroups have been classified on the basis of the chemical and serological properties of the capsular polysaccharide. Most cases of invasive disease are caused by serogroups A, B, C, Y and W135 [Reference Rosenstein2, Reference Peltola4]. A notable epidemiological feature of meningococcal disease is that the serogroup frequency of disease-associated isolates can vary over time and between different geographical regions [Reference Peltola4, Reference Harrison5].
Several molecular typing methods have been developed for use in epidemiological studies of N. meningitidis [Reference Maiden6–Reference Yakubu, Abadi and Pennington8]. Of these, multilocus sequence typing (MLST) is a very useful molecular method for tracking the national and global spread of meningococcal clones, and for identifying lineages that have an increased propensity to cause meningococcal disease [Reference Doyle9–Reference Yazdankhah15]. The population structure of N. meningitidis is effectively panmictic as a result of frequent horizontal genetic exchanges [Reference Smith16]. However, groups of N. meningitidis with highly related sequence types (STs) can persist for decades and spread as clonal populations. These groups are referred to as clonal complexes. Although members within a clonal complex are similar to each other, different clonal complexes are genetically dissimilar and easily distinguished by MLST [Reference Maiden6]. N. meningitidis isolates derived from carriers are more genetically diverse than strains associated with invasive disease. The majority of cases of meningococcal disease are caused by a limited number of clonal complexes, now termed hyperinvasive lineages [Reference Yazdankhah15, Reference Caugant17]. Strains isolated from carriers comprise numerous STs, with only a small proportion of the strains representing invasive clones. Transmissibility during the carriage state is an essential component of the life cycle of N. meningitidis. Co-colonization with other bacteria may lead to genetic exchange, which may result in the emergence of new meningococcal clones.
At any particular time and geographical location, the invasive strains of one hyperinvasive lineage usually belong to the same serogroup. ST7 serogroup A has been the most important serogroup in Africa and Asia, although ST11 serogroup W135 disease has also occurred recently in Africa. In other regions of the world, such as USA, Canada and Latin America, most meningococcal disease outbreaks have been caused by serogroups B, C and Y of several hyperinvasive lineages, e.g. ST11 and ST41/44 complexes [Reference Harrison5]. The MLST technique for characterizing N. meningitidis strains was adopted by the Chinese Center for Disease Control and Prevention (CDC) following the emergence of serogroup C meningococcal disease [Reference Shao14]. In combination with available epidemiological data, information on STs that cause sporadic cases and outbreaks in China has the potential to significantly enhance our understanding of diseases associated with N. meningitidis.
From the 1950s to the 1980s, more than 95% of meningococcal cases in China were caused by N. meningitidis serogroup A, with an annual disease rate of up to 500 cases/100 000 inhabitants. Serogroups B and C were less common and caused only sporadic cases of meningococcal meningitis [Reference Hu18]. A national immunization programme, using a serogroup A polysaccharide-based vaccine was initiated in the early 1980s, which involved the administration of four injections to each child: the first at age 6 months, the second 3 months later, the third at age 3 years, and the final one at age 6 years. During the following two decades only sporadic cases were reported. However, between 2003 and 2004 a new hyperinvasive lineage, the ST4821 complex, was identified in Anhui province. This lineage spread to 11 other Chinese provinces between 2004 and 2005, causing several outbreaks of serogroup C meningococcal disease and an increase in the number of serogroup C cases [Reference Shao14]. Following the initial serogroup C disease outbreak in 2003, a vaccination programme using a serogroup C polysaccharide-based vaccine, was initiated in conjunction with administration of serogroup A vaccine. A conjugate A+C vaccine was also used in some provinces. At present, more than 95% of meningococcal disease seen in China is caused by serogroups A or C N. meningitidis.
Given the unpredictability of N. meningitidis outbreaks and the increased prevalence of serogroup C strains after the introduction of serogroup A-based vaccines, we conducted an analysis of serogroups and STs among disease-associated and carrier N. meningitidis isolates that have emerged in China since 2003. The study investigated the distribution of serogroups and STs in a collection of 371 strains of meningococci isolated from individuals with meningococcal disease and asymptomatic carriers from 2003 to 2008. Studies such as ours have the potential to increase our knowledge of the molecular epidemiology of meningococcal disease, thereby increasing our ability to respond appropriately and effectively to disease outbreaks.
METHODS
Bacterial isolates and culture conditions
The study was conducted over a period of five academic years (from October to September of the following year). During this period, a total of 371 N. meningitidis strains were collected for analysis. The strains were isolated from 27 provinces in China between 2003 and 2008 (Table 1). All 27 provinces have laboratories that routinely collect pathogenic N. meningitidis isolates and periodically carry out surveys of N. meningitidis carriers for outbreak investigation, surveillance and research. Our laboratory requested that strains isolated by provincial CDCs were sent to our laboratory. Bacteria were identified by Gram stain, oxidase reaction, and standard biochemical tests using API® NH test kits (bioMérieux, France). N. meningitidis strains were serogrouped by slide agglutination using polyclonal antisera to different serogroups (Difco, France). Strains were stored at −80°C in brain heart broth with 15% sterile glycerol.
MLST
Fragments from seven housekeeping genes were used for typing: abcZ (putative ABC transporter), adk (adenylate kinase), aroE (shikimate dehydrogenase), fumC (fumarase), gdh (glucose-6-phosphate dehydrogenase), pdhC (pyruvate dehydrogenase subunit), and pgm (phosphoglucomutase), as given on the MLST website (http://pubmlst.org/neisseria/) [Reference Jolley, Chan and Maiden19]. Following DNA preparation and amplification by PCR, each locus sequence was analysed on an ABI Prism 3130 or 3730 DNA sequencer (Applied Biosystems, USA).
Data analysis
The sequence data were assembled using SeqMan II of the DNASTAR program (DNASTAR, USA). The sequences were compared with existing alleles on the MLST website in order to determine allele numbers, STs, and to assign the isolates to the correct clonal complexes. BioNumerics software (version 5.10; Applied Maths, USA) was used to create a minimum spanning tree [Reference Feil20]. In the minimum spanning tree, the founder ST was defined as the ST with the greatest number of single-locus variants.
RESULTS
Source and serogroup typing of N. meningitidis isolates
The 371 N. meningitidis isolates analysed in our study were isolated from 130 (35·0%) samples of cerebrospinal fluid or blood from patients, and 241 (65·0%) throat swab samples from healthy carriers. However, the carrier strains observed in this study are not truly representative of normal carriage, as some were associated with cases of invasive meningococcal disease. Of the 130 disease isolates, the two most common serogroups were C (76 isolates, 58·5%) and A (45, 34·6%), whereas serogroups B (5, 3·9%), W135 (3, 2·3%) and X (1, 0·8%) were less frequently observed. Of the 241 carrier isolates, the main serogroups were C (150, 62·2%), B (47, 19·5%) and A (23, 9·5%), followed by W135 (3, 1·2%), Z (1, 0·4%), X (1, 0·4%) and 29E (1, 0·4%). Serogrouping was not possible in 15 isolates, all of which were from the carrier group (Supplementary Table 1, available online).
Genotypic characterization of N. meningitidis isolates
There were 19 STs among the 130 disease isolates. Fifteen of the STs, representing 96·9% (126/130) of the isolates, could be assigned to five clonal complexes. Four STs, representing 3·1% (4/130) of the isolates, could not be assigned to any known clonal complexes (Supplementary Table 1). Of the 241 carrier isolates, 62 STs were identified. Twenty-nine of these STs could be assigned to eight clonal complexes (representing 81·3% of the isolates). Thirty-three of the STs could not be assigned to any known clonal complexes. Of the total number of 74 STs, only seven were shared between disease and carrier isolates.
ST4821 and ST5 complexes were the commonest clonal complexes in both disease and carrier isolates. Just over half (55·4%, 72/130) of the disease isolates and 62·2% (150/241) of the carrier isolates could be assigned to the ST4821 complex. The ST5 complex was present in 36·9% (48/130) and 11·2% (27/241) of the disease and carrier isolates, respectively. The remaining disease isolates were assigned to the ST11 complex (four isolates), ST103 complex (one isolate), and the ST32 complex (one isolate). Four isolates could not be assigned to a clonal complex.
There were more STs and clonal complexes in the carrier isolates. In addition to the ST4821 and ST5 complexes, the ST198 complex (seven isolates), ST41/44 complex (six isolates), ST1 complex (two isolates), ST32 complex (two isolates), ST11 complex (one isolate), and ST174 complex (one isolate) were also observed in the carrier isolates. Thirty-three STs (45 total isolates, with between 1 and 3 isolates in each ST) could not be assigned to any known complex.
Serogroup diversity of lineages
The serogroups varied in their genotypic diversity. Serogroup A and C isolates were conserved irrespective of source. Other serogroups and non-serogroupable isolates exhibited higher genotypic diversity in both disease and carrier isolates (Fig. 1). Most (94·1%) serogroup A isolates were associated with the ST5 complex and most (87·6%) serogroup C isolates with the ST4821 complex. There were no dominating STs in the other serogroups.
Some clonal complexes were strongly associated with particular serogroups, although these associations were not absolute (Supplementary Table 1, Fig. 1). Most of the ST4821 complex isolates belonged to serogroup C (198/222, 89·2%), for example, but a minority were identified as belonging to other serogroups, including serogroups B (14/222, 6·3%), A (1/222, 0·5%) or W135 (1/222, 0·5%). Eight (3·6%) members of this clonal complex could not be serogrouped. The ST5 complex was associated with isolates that belonged predominantly to serogroup A (64/75, 85·3%), with a minority belonging to serogroups C (8/75, 10·7%) and B (2/75, 2·7%). One isolate of the ST5 complex could not be serogrouped. Four of five ST11 complex isolates were W135. All isolates associated with ST41/44 and ST32 were serogroup B.
Nine STs contained isolates from different serogroups (Supplementary Table 1, Fig. 1). Most serogroups had isolates that belonged to ST2146 (ST198 complex). One isolate from serogroup B, two from serogroup C, one from serogroup X, one from serogroup 29E and two isolates that could not be serogrouped, all belonged to ST2146.
Temporal and geographical distribution of clonal complexes
The ST4821 and ST5 complexes were observed in each year of study, and were always the two most frequent complexes. Isolates of other clonal complexes and STs appeared more sporadically (Supplementary Table 2, available online). Between 2003 and 2008, frequencies of 5·5, 4·0, 4·3, 3·9 and 3·3 strains/ST were observed, with no upward or downward trend over the timeline of the study.
The occurrence of ST4821 and ST5 complexes was geographically diverse (Fig. 2). Isolates of the ST5 complex were found in 21 provinces spread across China, whereas isolates from the ST4821 complex were mainly concentrated in the eastern provinces. In most of the central and western provinces, only isolates from the ST5 clonal complex were observed. In the two central provinces of Sichuan and Gansu, where ST5 and ST4821 complexes co-exist, the ST5 complex was found more frequently. However, in the eastern regions where both complexes also co-exist, the ST4821 complex was found more frequently than the ST5 complex. Of the less frequently observed clonal complexes, ST11 was distributed in the southeastern region, and most (5/6) isolates in the ST41/44 complex were observed in Sichuan province.
DISCUSSION
In this study, MLST was used to investigate the molecular characteristics of N. meningitidis strains isolated in China between 2003 and 2008. The N. meningitidis strains tested in this study were isolated from 27 provinces in China between 2003 and 2008, which presumably represented the most abundant diversity of N. meningitidis strains in this period. The 130 disease-associated strains examined represent almost 1% of the cases seen in China between 2003 and 2008, and those from carriers were obtained from routine surveys of N. meningitidis. However, these carriers were not ‘normal’ in the strict sense, as there had been some association with invasive meningococcal disease. Notwithstanding, this study, which combines data from both disease-associated and normal carrier strains, provides the most representative data to date of the entire Chinese meningococcal population.
Of the isolates collected from patients, the main serogroups were C and A, and those collected from carriers, C, B and A. Two clones predominated, ST7 and ST4821, associated with serogroup A and serogroup C isolates, respectively. Isolates from other serogroups, and also isolates which could not be serogrouped, were highly diverse, with no single ST dominating.
Collections of meningococci recovered from healthy carriers exhibit greater genetic diversity than that observed in patients with invasive disease [Reference Yazdankhah15, Reference Climent21, Reference Jolley22]. The majority of cases of meningococcal disease reported to date are caused by a limited number of clonal complexes [Reference Caugant17]. Our data are consistent with these observations [Reference Zhang23]. Strains belonging to the ST1 (ST3) and ST5 complexes (ST5 and ST7) were responsible for almost all the meningococcal disease in China prior to 2003. Since 2003, most meningococcal disease has been caused by ST7 and ST4821 isolates. Isolates of other clonal complexes were only responsible for sporadic cases [Reference Shao24].
The ST7 clone emerged in China in the late 1980s, replacing the ST5 clone as the dominant cause of disease [Reference Zhang23]. This clone subsequently appeared in Mongolia (1994), Russia (1994–1997, 2003), Egypt (2000), and African countries (1995–2008) [Reference Nicolas25, 26]. The ST7 clone, which emerged in Africa in 1995 and 1997, appears to be responsible for a new wave of epidemics [Reference Nicolas13, Reference Nicolas25, Reference Nicolas27]. In this study, most of the serogroup A isolates were classified as ST7. No ST5 isolate was detected in China between 2005 and 2008. Previous data demonstrate that the ST7 serogroup A clone has been persistent in China since the late 1980s. Recent outbreaks of serogroup A disease have occurred in India [Reference Nair28] and the Philippines in 2005 [29]. Using the MLST database, the disease-causing strain responsible for the outbreak in the Philippines was identified as ST7 [26]. Based on limited studies of typing N. meningitidis isolates, no ST7 serogroup A isolate was found in any other Asian country between 2003 and 2008 [Reference Bae and Kang30, Reference Takahashi31].
In 2003, in Anhui province of China, ST4821 serogroup C isolates were responsible for increased incidence of meningococcal infections. To date, this lineage has only been found in China and has become more common than the ST7 serogroup A strain in the eastern region of the country. In addition, this new hyperinvasive lineage is now spreading across China, with meningococcal epidemics occurring throughout the entire country over the past 50 years. Fortunately, the ST4821 complex is not the most dominant lineage found in these provinces so far.
Capsular switching in a meningococcal isolate is said to occur when a ST in a serogroup not generally associated with that clonal complex is observed [Reference Swartley32, Reference Vogel, Claus and Frosch33]. This phenomenon is not infrequent and has been observed worldwide [Reference Mayer12, Reference Beddek34–Reference Tsang38]. In this study, we also observed several STs that belonged to different serogroups, suggesting a high degree of capsular switching. For example, there were some serogroup B isolates associated with ST4821. This was also observed in China in the 1980s [Reference Yang39], suggesting that capsular switching between serogroup B and C isolates could have occurred before or after the ST4821 serogroup C disease outbreak in 2003. In the current study, several serogroup C isolates belonged to ST7. Thus, since most ST7 isolates belong to serogroup A, capsular switching could explain the appearance of the ST7 serogroup C strains. By sequencing and comparing the whole capsular gene clusters and surrounding genes, Wang et al. confirmed that recombination is the genetic basis of capsular switching between ST7 serogroup A and C strains [Reference Wang40]. As details surrounding capsular switching in N. meningitidis remain unclear, continued surveillance is needed.
This study is the first to investigate the diversity of N. meningitidis STs and their geographical distribution in China since the emergence of serogroup C strains post-introduction of serogroup A-based vaccines. Using the MLST technique, we typed 371 different N. meningitidis strains isolated over a 5-year period. The ST4821 and ST5 complexes were the two most commonly occurring clonal complexes in both disease and carrier (albeit not truly representative of a normal carrier) isolates in China. The ST5 complex has been persistent in China since the late 1980s and has spread throughout the entire country. Isolates belonging to the ST4821 complex have appeared as a dominant lineage since 2003, particularly in eastern China.
NOTE
Supplementary material accompanies this paper on the Journal's website (http://journals.cambridge.org/hyg).
ACKNOWLEDGEMENTS
This study was supported by grants from the Ministry of Health and the Ministry of Science and Technology (2011CB504900 and 2008ZX10004-008), People's Republic of China.
DECLARATION OF INTEREST
None.